Armistice Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30M | Buy |
1,600,000
+84,000
| +6% | +$1.57M | 0.52% | 26 |
|
|
2025
Q1 | $27.3M | Buy |
1,516,000
+364,000
| +32% | +$6.55M | 0.41% | 47 |
|
|
2024
Q4 | $19.4M | Sell |
1,152,000
-384,000
| -25% | -$6.46M | 0.26% | 74 |
|
|
2024
Q3 | $24.9M | Sell |
1,536,000
-88,000
| -5% | -$1.42M | 0.4% | 43 |
|
|
2024
Q2 | $13.3M | Buy |
1,624,000
+88,000
| +6% | +$723K | 0.17% | 80 |
|
|
2024
Q1 | $22.7M | Sell |
1,536,000
-174,000
| -10% | -$2.58M | 0.3% | 52 |
|
|
2023
Q4 | $24.8M | Sell |
1,710,000
-3,600
| -0.2% | -$52.2K | 0.34% | 49 |
|
|
2023
Q3 | $18.5M | Buy |
1,713,600
+3,600
| +0.2% | +$38.9K | 0.28% | 58 |
|
|
2023
Q2 | $22.1M | Buy |
1,710,000
+7,600
| +0.4% | +$98K | 0.32% | 57 |
|
|
2023
Q1 | $22.5M | Buy |
1,702,400
+6,800
| +0.4% | +$89.8K | 0.32% | 55 |
|
|
2022
Q4 | $25.4M | Buy |
1,695,600
+1,350,313
| +391% | +$20.3M | 0.44% | 43 |
|
|
2022
Q3 | $4.07M | Buy |
+345,287
| New | +$4.07M | 0.07% | 101 |
|
|
2020
Q3 | – | Sell |
-52,270
| Closed | -$957K | – | 116 |
|
|
2020
Q2 | $957K | Buy |
+52,270
| New | +$957K | 0.04% | 75 |
|